Adherence to pharmacological and nonpharmacological treatments in adults with type 2 diabetes
DOI: 10.15343/0104-7809.202044381396
Keywords:
Diabetes Mellitus. Primary Health Care. Cooperation and Adherence to Treatment. Pharmacological treatment. Noncommunicable Diseases.Abstract
Treatment in diabetes is basically performed by pharmacological and nonpharmacological (physical activity and nutrition)
therapies. However, adherence to treatment is a constant challenge, requiring a greater understanding and direction of
the multiple aspects that can interfere with adherence to these different types of treatment. Therefore, the study sought
to estimate the prevalence of aspects that influence adherence to pharmacological and nonpharmacological treatments
of people living with type 2 diabetes. This was a descriptive and cross-sectional study, with 139 users, registered and
participating in programs aimed at the diabetic population in a Basic Family Health Unit in the city of Manaus, Amazonas,
Brazil. Data were collected through an interview using a semi-structured form with questions related to sociodemographic,
economic, clinical and health aspects in general, and pharmacological and nonpharmacological treatments (physical activity
and nutrition). The prevalence of adherence to pharmacological treatments was the highest (74.8%), followed by adherence
only to physical activity (56.1%). There was a low prevalence of adherence only to nutrition (10.2%). When estimating the
combined prevalence, pharmacological treatments associated with physical activity was the most prevalent (40.3%). The
combined adherence between pharmacological and nonpharmacological treatments (physical activity and nutrition) was
low (5.8%). The study concludes by reinforcing that the action of the multiprofessional health team is a fundamental tool that
acts with a comprehensive approach to promoting, preventing and maintaining health and that it can contribute to greater
adherence to the treatment of users with type 2 diabetes.
Downloads
References
classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med. 1998;15(7):539–553.
2. Oliveira JEP, Montenegro Junior RM, Vencio S. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018. Sociedade Brasileira de
Diabetes. São Paulo: Editora Clannad, 2017.
3. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Estratégias para o cuidado da pessoa
com doença crônica: diabetes mellitus. Cadernos de Atenção Básica. 2013;(36).
4. Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil:
burden and current challenges. Lancet. 2011;377(9781):1949–1961.
5. Campos CMS, Mishima SM. Health needs according to civil society and the state. Cad Saude Publica. 2005;21(4):1260–1268.
6. Brasil. Portaria no 2.436, de 21 de setembro de 2017. Aprova a Política Nacional de Atenção Básica, estabelecendo a revisão de
diretrizes para a organização da Atenção Básica, no âmbito do Sistema Único de Saúde (SUS). Diário Oficial da União. 2017;183(1).
7. Farias MS, Agra CCM, Araújo LK, Correia DS, Cavalcante JC. Treatment adherence and life quality of diabetic patients assisted in the
primary care division. Rev Soc Bras Clin Med. 2014;12(2):102–7.
8. Boas L, Foss MC, Foss-Freitas MC, Torres H de C, Monteiro LZ, Pace AE. Adesão à dieta e ao exercício físico das pessoas com
diabetes mellitus. Texto & contexto enferm. 2011;20(2):272–9.
9. Florindo AA, Hallal PC. Epidemiologia da atividade física. São Paulo: Editora Atheneu; 2011.
10. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes – 2019. Diabetes
care. 2019;42(Supplement 1):S13–S28.
11. World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.
12. Grillo FM, Gorini MI. Characterization of people with diabetes mellitus type 2. Rev Bras Enferm. 2007;60(1):49–54.
13. Navarro JHN, Andrade FP, Paiva TS, Silva DO, Gessinger CF, Bós ÂJG. Percepção dos idosos jovens e longevos gaúchos quantoaos espaços públicos em que vivem. Cien Saude Colet. 2015;20(2):461–70.
14. Marfell-Jones MJ, Stewart AD, De Ridder JH. International standards for anthropometric assessment. 2012.
15. Status WP. The use and interpretation of anthropometry. WHO technical report series. 1995;854(9).
16. World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organization; 2000.
17. Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira LC, et al. International physical activity questionnaire (IPAQ):
study of validity and reliability in Brazil. Rev Bras Ativ Fis Saúde. 2001;6(2):5–18.
18. Michels MJ, Coral MH, Sakae TM, Damas TB, Furlanetto LM. Questionnaire of Diabetes Self-Care Activities: translation, crosscultural
adaptation and evaluation of psychometric properties. Arq Bras Endocrinol Metab. 2010;54(7):644–651.
19. Boas LCG-V, Foss-Freitas MC, Pace AE. Adherence of people with type 2 diabetes mellitus to drug treatment. Rev Bras Enferm.
2014;67(2):268–273.
20. Faria HTG, Rodrigues FFL, Zanetti ML, Araújo MFM, Damasceno MMC. Factors associated with adherence to treatment of patients
with diabetes mellitus. Acta Paul Enferm. 2013;26(3):231–237.
21. Medtler K, Perassolo MS. Avaliação da adesão ao tratamento anti-hipertensivo e antidiabético de um grupo hiperdia do município
de Presidente Lucena-RS. Rev Conhec Online. 2016;2:35–46.
22. Albuquerque GA, Leite MF, Belém JM, Nunes JFC, Oliveira MA, Adami F. The man in primary healthcare: perceptions of nurses
about the implications of gender in health. Esc Anna Nery. 2014;18(4):607–614.
23. Gimenes HT, Zanetti ML, Haas VJ. Factors related to patient adherence to antidiabetic drug therapy. Rev Latino-Am Enfermagem.
2009;17(1):46–51.
24. Groff DP, Simões PWTA, Fagundes ALSC. Adesão ao tratamento dos pacientes diabéticos tipo II usuários da estratégia saúde da
família situada no bairro Metropol de Criciúma, SC. Arq Catarin Med. 2011;40(3):43–8.
25. Winkelmann ER, Fontela PC, Winkelmann ER, Fontela PC. Condições de saúde de pacientes com diabetes mellitus tipo 2 cadastrados
na Estratégia Saúde da Família, em Ijuí, Rio Grande do Sul, 2010-2013. Epidemiol Serv Saúde. 2014;23(4):665–74.
26. Vergara MS, Jesus AS, Pellanda LC, Vilela MAP. Epidemiological and ophthalmological findings in diabetic patients examined in a
general hospital. Rev Bras Oftalmol. 2014;73( 3 ): 167-170. 2014.
27. Mauri-Obradors E, Estrugo-Devesa A, Jané-Salas E, Viñas M, López-López J. Oral manifestations of Diabetes Mellitus. A systematic
review. Med Oral Patol Oral Cir Bucal. 2017;22(5):e586–94.
28. Faria HTG, Santos MA, Arrelias CCA, Rodrigues FFL, Gonela JT, Teixeira CRS, et al. Adesão ao tratamento em diabetes mellitus em
unidades da Estratégia Saúde da Família. Rev Esc Enferm USP. 2014;48(2):257–263.
29. American Diabetes Association. Standards of Medical Care in Diabetes. In: Diabetes Care [Internet]. American Diabetes Association;
2020 [citado 30 de julho de 2020]. p. 1–224. Disponível em: https://care.diabetesjournals.org/content/28/suppl_1/s4
30. American College of Sports Medicine. Diretrizes do ACSM para os Testes de Esforço e sua Prescrição. São Paulo: livro Diretrizesdo ACSM para os Testes de Esforço e sua Prescrição; 2014.
31. Johnson ST, Mundt C, Soprovich A, Wozniak L, Plotnikoff RC, Johnson JA. Healthy eating and active living for diabetes in primary
care networks (HEALD-PCN): rationale, design, and evaluation of a pragmatic controlled trial for adults with type 2 diabetes. BMC
Public Health. 2012;12(1):1–9.
32. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in
type 2 diabetic patients: a meta-analysis. Diabetes care. 2006;29(11):2518–2527.
33. Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity
in individuals with prediabetes. Diabetes care. 2012;35(1):131–136.
34. Bello DMA, Araújo NC, Gusmão ES, Souza PRE, Donos N, Cimões R. Periodontal Conditions and Metabolic Control Markers in
Diabetic Patients. Pesqui Bras Odontopediatria Clín Integr. 2012;11(3):357–61.